ABCL
Abcellera Biologics Inc
11.00$
+5.9%
vs. previous close
Closing price · As of: Aug 13, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Abcellera Biologics Inc (ABCL) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/13/2026 | Current report (8-K) | AbCellera Biologics Inc. (ABCL): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.